Wall Street predicts Sonoma Pharmaceuticals Inc. (SNOA) stock to surge by 1547.37%

A share price of Sonoma Pharmaceuticals Inc. [SNOA] is currently trading at $0.19, up 20.26%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SNOA shares have gain 22.41% over the last week, with a monthly amount drifted -68.58%, and not seem to be holding up well over a long-time horizon.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


On 13, November 2023, Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results. In a post published today on Yahoo Finance, Gross profit percentage of 36% for the quarter, up 1% from first fiscal quarter 2024.

From an analyst’s perspective:

Sonoma Pharmaceuticals Inc. experienced fluctuations in its stock price throughout the past year between $0.12 and $2.68. Currently, Wall Street analysts expect the stock to reach $3.13 within the next 12 months. Sonoma Pharmaceuticals Inc. [NASDAQ: SNOA] shares were valued at $0.19 at the most recent close of the market. An investor can expect a potential return of 1547.37% based on the average SNOA price forecast.

Analyzing the SNOA fundamentals

During the last quarter, Sonoma Pharmaceuticals Inc. [NASDAQ:SNOA] saw sales of 2.73 billion, an decline of -18.01%. During this period, the public company’s revenue per employee was $77,614, while its income per employee was -$30,123. Gross Margin for this corporation currently stands at +33.73% with Operating Margin at -34.43%, Pretax Margin comes in at -39.06%, and Net Margin reading is -38.81%. To continue investigating profitability, this company’s Return on Assets is posted at -28.94, Equity is -61.78, Total Capital is -48.39, and Invested Capital is -60.09. An extended look at the Principal structure reveals enduring liabilities to the total capital of 9.62 and enduring liabilities to assets of 5.17.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.1705 points at the first support level, and at 0.1492 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.2025, and for the 2nd resistance point, it is at 0.2132.

Sonoma Pharmaceuticals Inc. [SNOA] reported earnings per share of -$0.29 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.24/share, meaning a difference of -$0.05 and a surprise factor of -20.80%.

Ratios To Look Out For

A current ratio of 3.48 is a noteworthy aspect of Sonoma Pharmaceuticals Inc. [NASDAQ:SNOA]. In addition, the Quick Ratio stands at 2.88 and the Cash Ratio stands at 1.03. Considering the valuation of this stock, the price to sales ratio is 0.25, the price to book ratio is 0.60.